A Lysosome-Targeted Tetrazine for Organelle-Specific Click-to-Release Chemistry in Antigen Presenting Cells
Overview
Authors
Affiliations
Bioorthogonal deprotections are readily used to control biological function in a cell-specific manner. To further improve the spatial resolution of these reactions, we here present a lysosome-targeted tetrazine for an organelle-specific deprotection reaction. We show that -cyclooctene deprotection with this reagent can be used to control the biological activity of ligands for invariant natural killer T cells in the lysosome to shed light on the processing pathway in antigen presenting cells. We then use the lysosome-targeted tetrazine to show that long peptide antigens used for CD8 T cell activation do not pass through this organelle, suggesting a role for the earlier endosomal compartments for their processing.
Park M, Nam J, Kim T, Yoon G, Kim S, Lee C Adv Sci (Weinh). 2024; 12(2):e2407236.
PMID: 39540573 PMC: 11727131. DOI: 10.1002/advs.202407236.
Jann C, Giofre S, Bhattacharjee R, Lemke E Chem Rev. 2024; 124(18):10281-10362.
PMID: 39120726 PMC: 11441406. DOI: 10.1021/acs.chemrev.3c00878.
Venrooij K, de Bondt L, Bonger K Top Curr Chem (Cham). 2024; 382(3):24.
PMID: 38971884 PMC: 11227474. DOI: 10.1007/s41061-024-00467-8.
He X, Li J, Liang X, Mao W, Deng X, Qin M Nat Commun. 2024; 15(1):2831.
PMID: 38565562 PMC: 10987521. DOI: 10.1038/s41467-024-47188-6.
Organelle Targeted Drug Delivery: Key Challenges, Recent Advancements and Therapeutic Implications.
Singh D Endocr Metab Immune Disord Drug Targets. 2024; 24(13):1480-1487.
PMID: 38303531 DOI: 10.2174/0118715303282573240112104035.